Goldman Sachs adjusts its forecast for the size of the weight loss drug market and raises the market development potential outside the United States

2025-05-26 20:21:26

Goldman Sachs previously predicted that the weight loss drug market would reach $130 billion by 2030, but now it has become $95 billion. Goldman Sachs also lowered its peak forecast for the U.S. weight loss drug market to $70 billion, while raising its peak forecast for the "non-U.S." market to $50 billion. Goldman Sachs emphasized that existing market participants and new entrants will still have significant growth opportunities.

weight loss drug

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Hong Kong stocks opened: Hang Seng Index opened 0.14% higher, Hang Seng Technology Index opened 0.13% higher
                            2025-06-06

                                    A U.S. appeals court rejected Apple's (AAPL.O) request to suspend an order on App Store reforms in its lawsuit against Epic Games, court documents showed.
                            2025-06-05

                                    Cainiao continues to deploy logistics + AI and joins hands with China Eastern Airlines to build the world's first smart hangar
                            2025-06-06

                                    South Korea's exports fell 1.3% in May from a year earlier
                            2025-06-01

                                    Project establishment and formulation of safety requirements for combined driving assistance systems for intelligent connected vehicles
                            2025-06-04